Table 2.
Resting eNO | Post-exercise eNO | |||
---|---|---|---|---|
Variables | Correlation (r) | p value | Correlation (r) | p value |
Echocardiographic Variables | ||||
RVSP | 0.40 | 0.13 | 0.57 | 0.0009 |
LAVI | 0.16 | 0.55 | 0.43 | 0.014 |
LVEF | −0.016 | 0.95 | −0.11 | 0.29 |
Right Tei index | 0.0049 | 0.98 | 0.09 | 0.62 |
LVDD | 0.20 | 0.45 | 0.27 | 0.13 |
LVESVI | −0.052 | 0.84 | 0.24 | 0.19 |
ADMA/L-arginine | ||||
ADMA | −0.08 | 0.74 | −0.02 | 0.88 |
L-Arginine | −0.21 | 0.41 | −0.09 | 0.61 |
L-Arginine/ADMA ratio | −0.03 | 0.89 | −0.02 | 0.89 |
Cardiopulmonary Exercise Variables | ||||
peak VO2 | −0.44 | 0.08 | −0.18 | 0.31 |
VE/VCO2 | 0.22 | 0.40 | 0.17 | 0.33 |
Exercise duration | −0.46 | 0.06 | −0.15 | 0.42 |
Clinical Variables | ||||
KCCQ Total symptom score | 0.14 | 0.65 | 0.17 | 0.36 |
Abbreviations: eNO = exhaled nitric oxide; RVSP = right ventricular systolic pressure; LAVI = left atrial volume index; LVEF = left ventricular ejection fraction; LVEDD = left ventricular diastolic dimension; LVESVI = left ventricular end-systolic volume index; ADMA = asymmetric dimethylarginine; VO2 = ventilatory oxygen uptake; VE/VCO2 = ventilatory equivalent ratio for carbon dioxide; KCCQ = Kansas City Cardiomyopathy Questionnaire